Abman Steve, Jobe Alan, Chernick Victor, Blaisdell Carol, Castro Mario, Ramirez Maria I, Gern James E, Cutting Garry, Redding Greg, Hagood James S, Whitsett Jeffrey, Abman Steve, Raj J Usha, Barst Robyn, Kato Gregory J, Gozal David, Haddad Gabriel G, Prabhakar Nanduri R, Gauda Estelle, Martinez Fernando D, Tepper Robert, Wood Robert E, Accurso Frank, Teague W Gerald, Venegas Jose, Cole F Sessions, Wright Rosalind J, Gail Dorothy, Hamvas Aaron, Kercsmar Carolyn, Kiley James, Weinmann Gail
Washington University School of Medicine, Medicine and Pediatrics, St. Louis, Missouri.
Pediatr Pulmonol. 2009 Jan;44(1):2-13. doi: 10.1002/ppul.20973.
The Division of Lung Diseases of the National Heart, Lung and Blood Institute (NHLBI) recently held a workshop to identify gaps in our understanding and treatment of childhood lung diseases and to define strategies to enhance translational research in this field. Leading experts with diverse experience in both laboratory and patient-oriented research reviewed selected areas of pediatric lung diseases, including perinatal programming and epigenetic influences; mechanisms of lung injury, repair, and regeneration; pulmonary vascular disease (PVD); sleep and control of breathing; and the application of novel translational methods to enhance personalized medicine. This report summarizes the proceedings of this workshop and provides recommendations for emphasis on targeted areas for future investigation. The priority areas identified for research in pediatric pulmonary diseases included: (1) epigenetic and environmental influences on lung development that program pediatric lung diseases, (2) injury, regeneration, and repair in the developing lung, (3) PVD in children, (4) development and adaptation of ventilatory responses to postnatal life, (5) nonatopic wheezing: aberrant large airway development or injury? (6) strategies to improve assessment, diagnosis, and treatment of pediatric respiratory diseases, and (7) predictive and personalized medicine for children.
美国国立心肺血液研究所(NHLBI)肺病科最近举办了一次研讨会,以找出我们在儿童肺部疾病的认识和治疗方面存在的差距,并确定加强该领域转化研究的策略。在实验室研究和以患者为导向的研究方面有着丰富经验的顶尖专家,对小儿肺部疾病的选定领域进行了评审,包括围产期编程和表观遗传影响;肺损伤、修复和再生的机制;肺血管疾病(PVD);睡眠与呼吸控制;以及应用新型转化方法来加强个性化医疗。本报告总结了本次研讨会的会议记录,并为未来重点研究的目标领域提供了建议。确定的小儿肺部疾病研究优先领域包括:(1)表观遗传和环境对肺部发育的影响,这些影响会引发小儿肺部疾病;(2)发育中肺部的损伤、再生和修复;(3)儿童的肺血管疾病;(4)出生后通气反应的发育和适应;(5)非特应性喘息:大气道发育异常还是损伤?(6)改善小儿呼吸道疾病评估、诊断和治疗的策略;以及(7)儿童的预测性和个性化医疗。